-transparent.png){kind=logo}
Using a variety of techniques, estrogen and progesterone receptors have previously been identified in variable percentages of malignant melanomas. We examined 10 primary superficial spreading melanomas (SSM) with a fluorescent hormone-binding technique for estrogen and progesterone cytoplasmic receptors. Of these 6 SSM were markedly positive for estrogen and progesterone binding. Patients with dysplastic nevus syndrome (DNS) or a family history of DNS were markedly positive for estrogen and progesterone binding. A single patient with lentigo maligna and another patient with lentigo maligna melanoma were negative for estrogen and progesterone binding. None of the 21 control intradermal nevi examined for estrogen and progesterone binding exhibited marked positivity.
D L Ellis, and
R G Wheeland, and
H Solomon
January 1991,
Neoplasma,
D L Ellis, and
R G Wheeland, and
H Solomon
January 1980,
Cancer treatment reports,
D L Ellis, and
R G Wheeland, and
H Solomon
February 2014,
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie,
D L Ellis, and
R G Wheeland, and
H Solomon
September 1991,
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc,
D L Ellis, and
R G Wheeland, and
H Solomon
December 1999,
Nihon rinsho. Japanese journal of clinical medicine,
D L Ellis, and
R G Wheeland, and
H Solomon
July 2010,
Nihon rinsho. Japanese journal of clinical medicine,
D L Ellis, and
R G Wheeland, and
H Solomon
May 1983,
Gan no rinsho. Japan journal of cancer clinics,
D L Ellis, and
R G Wheeland, and
H Solomon
September 1994,
Chinese medical journal,
D L Ellis, and
R G Wheeland, and
H Solomon
May 1994,
Zhonghua fu chan ke za zhi,
D L Ellis, and
R G Wheeland, and
H Solomon
January 1985,
Pathologie-biologie,
